13价肺炎球菌结合疫苗接种前后hiv感染儿童肺炎链球菌的鼻咽携带及血清型分布

IF 2.1 Q4 IMMUNOLOGY
Clinical and Experimental Vaccine Research Pub Date : 2025-04-01 Epub Date: 2025-03-31 DOI:10.7774/cevr.2025.14.e19
Wisiva Tofriska Paramaiswari, Dina Muktiarti, Dodi Safari, Rizqi Amalia, Melati Padma, Yayah Winarti, Miftahuddin Majid Khoeri, Wa Ode Dwi Daningrat, Wisnu Tafroji, Amin Soebandrio
{"title":"13价肺炎球菌结合疫苗接种前后hiv感染儿童肺炎链球菌的鼻咽携带及血清型分布","authors":"Wisiva Tofriska Paramaiswari, Dina Muktiarti, Dodi Safari, Rizqi Amalia, Melati Padma, Yayah Winarti, Miftahuddin Majid Khoeri, Wa Ode Dwi Daningrat, Wisnu Tafroji, Amin Soebandrio","doi":"10.7774/cevr.2025.14.e19","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The objective of this study was to determine the prevalence of colonization, serotype distribution, and antimicrobial susceptibility profile of <i>Streptococcus pneumoniae</i> (Pneumococcus) isolated from human immunodeficiency virus (HIV)-infected children before and after single-dose of 13-valent pneumococcal conjugate vaccine (PCV13) vaccination.</p><p><strong>Materials and methods: </strong>We conducted a prospective cohort study among HIV-infected children above six years of age in Jakarta, Indonesia. Nasopharyngeal swabs were collected from 50 children before vaccination, 12 months, and 18 months after PCV13 vaccination. The swabs were evaluated by bacterial culture, and serotyping were performed using sequential multiplex polymerase chain reactions and Quellung reactions. Antimicrobial susceptibility profiles were determined using the disk diffusion method.</p><p><strong>Results: </strong>We found <i>Streptococcus pneumoniae</i> colonized 46% (23/50) of total children enrolled before vaccination, which decreased to 19% (n=9/47) at 12 months post-vaccination and 29% (14/48) at 18 months post-vaccination. There was no significant difference in the prevalence of pneumococcal colonization between vaccinated and unvaccinated HIV-infected children (p>0.05). There was a significant decrease in pneumococcal colonization between the baseline, 12 months, and 18 months after vaccination among vaccinated children (p<0.05). Vaccine-type (VT) serotypes (6B, 23F, and 19A) were more prevalent than non-vaccine serotypes before vaccination. Non-vaccine type (NVT) serotypes (6C, 15C) were more prevalent at 12 months post-vaccination. VT serotypes were found at 18 months post-vaccination in vaccinated children. There was a high prevalence of antimicrobial resistance to <i>S. pneumoniae</i> isolates to oxacillin, tetracycline, and sulfamethoxazole-trimethoprim before and after vaccination.</p><p><strong>Conclusion: </strong>There was a decrease in pneumococcal carriage after PCV vaccination in HIV-infected children, accompanied by changes in serotype distribution from VT serotypes to NVT serotypes.</p>","PeriodicalId":51768,"journal":{"name":"Clinical and Experimental Vaccine Research","volume":"14 2","pages":"127-137"},"PeriodicalIF":2.1000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12046085/pdf/","citationCount":"0","resultStr":"{\"title\":\"Nasopharyngeal carriage and serotype distribution of <i>Streptococcus pneumoniae</i> among HIV-infected children aged >6 years: before and after vaccination of 13-valent pneumococcal conjugate vaccine.\",\"authors\":\"Wisiva Tofriska Paramaiswari, Dina Muktiarti, Dodi Safari, Rizqi Amalia, Melati Padma, Yayah Winarti, Miftahuddin Majid Khoeri, Wa Ode Dwi Daningrat, Wisnu Tafroji, Amin Soebandrio\",\"doi\":\"10.7774/cevr.2025.14.e19\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>The objective of this study was to determine the prevalence of colonization, serotype distribution, and antimicrobial susceptibility profile of <i>Streptococcus pneumoniae</i> (Pneumococcus) isolated from human immunodeficiency virus (HIV)-infected children before and after single-dose of 13-valent pneumococcal conjugate vaccine (PCV13) vaccination.</p><p><strong>Materials and methods: </strong>We conducted a prospective cohort study among HIV-infected children above six years of age in Jakarta, Indonesia. Nasopharyngeal swabs were collected from 50 children before vaccination, 12 months, and 18 months after PCV13 vaccination. The swabs were evaluated by bacterial culture, and serotyping were performed using sequential multiplex polymerase chain reactions and Quellung reactions. Antimicrobial susceptibility profiles were determined using the disk diffusion method.</p><p><strong>Results: </strong>We found <i>Streptococcus pneumoniae</i> colonized 46% (23/50) of total children enrolled before vaccination, which decreased to 19% (n=9/47) at 12 months post-vaccination and 29% (14/48) at 18 months post-vaccination. There was no significant difference in the prevalence of pneumococcal colonization between vaccinated and unvaccinated HIV-infected children (p>0.05). There was a significant decrease in pneumococcal colonization between the baseline, 12 months, and 18 months after vaccination among vaccinated children (p<0.05). Vaccine-type (VT) serotypes (6B, 23F, and 19A) were more prevalent than non-vaccine serotypes before vaccination. Non-vaccine type (NVT) serotypes (6C, 15C) were more prevalent at 12 months post-vaccination. VT serotypes were found at 18 months post-vaccination in vaccinated children. There was a high prevalence of antimicrobial resistance to <i>S. pneumoniae</i> isolates to oxacillin, tetracycline, and sulfamethoxazole-trimethoprim before and after vaccination.</p><p><strong>Conclusion: </strong>There was a decrease in pneumococcal carriage after PCV vaccination in HIV-infected children, accompanied by changes in serotype distribution from VT serotypes to NVT serotypes.</p>\",\"PeriodicalId\":51768,\"journal\":{\"name\":\"Clinical and Experimental Vaccine Research\",\"volume\":\"14 2\",\"pages\":\"127-137\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12046085/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Vaccine Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7774/cevr.2025.14.e19\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/3/31 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Vaccine Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7774/cevr.2025.14.e19","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/31 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究的目的是确定在单剂量13价肺炎球菌结合疫苗(PCV13)接种前后,从感染人类免疫缺陷病毒(HIV)的儿童中分离出的肺炎球菌(肺炎球菌)的定植率、血清型分布和抗菌药物敏感性。材料和方法:我们在印度尼西亚雅加达6岁以上感染艾滋病毒的儿童中进行了一项前瞻性队列研究。在接种PCV13疫苗前、接种后12个月和18个月收集50名儿童的鼻咽拭子。通过细菌培养对拭子进行评估,并使用顺序多重聚合酶链反应和Quellung反应进行血清分型。采用纸片扩散法测定其药敏谱。结果:我们发现肺炎链球菌定植率为接种前的46%(23/50),接种后12个月降至19% (n=9/47),接种后18个月降至29%(14/48)。接种疫苗和未接种疫苗的艾滋病毒感染儿童的肺炎球菌定植率无显著差异(p < 0.05)。在接种疫苗的儿童中,在基线、接种疫苗后12个月和18个月之间,肺炎球菌定植量显著下降(接种前后分别接种了oxacillin、四环素和磺胺甲恶唑-甲氧苄啶的肺炎球菌分离株)。结论:hiv感染儿童接种PCV后肺炎球菌携带率下降,血清型分布由VT型向NVT型转变。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Nasopharyngeal carriage and serotype distribution of Streptococcus pneumoniae among HIV-infected children aged >6 years: before and after vaccination of 13-valent pneumococcal conjugate vaccine.

Purpose: The objective of this study was to determine the prevalence of colonization, serotype distribution, and antimicrobial susceptibility profile of Streptococcus pneumoniae (Pneumococcus) isolated from human immunodeficiency virus (HIV)-infected children before and after single-dose of 13-valent pneumococcal conjugate vaccine (PCV13) vaccination.

Materials and methods: We conducted a prospective cohort study among HIV-infected children above six years of age in Jakarta, Indonesia. Nasopharyngeal swabs were collected from 50 children before vaccination, 12 months, and 18 months after PCV13 vaccination. The swabs were evaluated by bacterial culture, and serotyping were performed using sequential multiplex polymerase chain reactions and Quellung reactions. Antimicrobial susceptibility profiles were determined using the disk diffusion method.

Results: We found Streptococcus pneumoniae colonized 46% (23/50) of total children enrolled before vaccination, which decreased to 19% (n=9/47) at 12 months post-vaccination and 29% (14/48) at 18 months post-vaccination. There was no significant difference in the prevalence of pneumococcal colonization between vaccinated and unvaccinated HIV-infected children (p>0.05). There was a significant decrease in pneumococcal colonization between the baseline, 12 months, and 18 months after vaccination among vaccinated children (p<0.05). Vaccine-type (VT) serotypes (6B, 23F, and 19A) were more prevalent than non-vaccine serotypes before vaccination. Non-vaccine type (NVT) serotypes (6C, 15C) were more prevalent at 12 months post-vaccination. VT serotypes were found at 18 months post-vaccination in vaccinated children. There was a high prevalence of antimicrobial resistance to S. pneumoniae isolates to oxacillin, tetracycline, and sulfamethoxazole-trimethoprim before and after vaccination.

Conclusion: There was a decrease in pneumococcal carriage after PCV vaccination in HIV-infected children, accompanied by changes in serotype distribution from VT serotypes to NVT serotypes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.70
自引率
3.70%
发文量
29
审稿时长
8 weeks
期刊介绍: Clin Exp Vaccine Res, the official English journal of the Korean Vaccine Society, is an international, peer reviewed, and open-access journal. It covers all areas related to vaccines and vaccination. Clin Exp Vaccine Res publishes editorials, review articles, special articles, original articles, case reports, brief communications, and correspondences covering a wide range of clinical and experimental subjects including vaccines and vaccination for human and animals against infectious diseases caused by viruses, bacteria, parasites and tumor. The scope of the journal is to disseminate information that may contribute to elaborate vaccine development and vaccination strategies targeting infectious diseases and tumors in human and animals. Relevant topics range from experimental approaches to (pre)clinical trials for the vaccine research based on, but not limited to, basic laboratory, translational, and (pre)clinical investigations, epidemiology of infectious diseases and progression of all aspects in the health related issues. It is published printed and open accessed online issues (https://ecevr.org) two times per year in 31 January and 31 July. Clin Exp Vaccine Res is linked to many international databases and is made freely available to institutions and individuals worldwide
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信